1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1.
Markets Covered
1.2.2.
Years Considered for
Study
1.2.3.
Key Market
Segmentations
2.
Research Methodology
2.1.
Objective of the Study
2.2.
Baseline Methodology
2.3.
Key Industry Partners
2.4.
Major Association and Secondary Sources
2.5.
Forecasting Methodology
2.6.
Data Triangulation & Validation
2.7.
Assumptions and Limitations
3.
Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Global E-Prescribing Market Outlook
4.1.
Market Size &
Forecast
4.1.1.
By Value
4.2.
Market Share &
Forecast
4.2.1. By Product
(Solutions (Integrated Solutions, Standalone
Solutions), Services(Support, Implementation,
Training, Network)
4.2.2. By Specialties
(Oncology, Sports
Medicine, Neurology, Cardiology,
Others)
4.2.3. By Delivery Mode
(Web/Cloud Based, On
Premise)
4.2.4. By Substances
(Controlled Substances, Non-controlled
Substances)
4.2.5.
By Region
4.2.6.
By Company (2023)
4.3.
Market Map
4.3.1.
By Product
4.3.2.
By Specialties
4.3.3.
By Delivery Mode
4.3.4.
By Substances
4.3.5.
By Region
5. Asia Pacific E-Prescribing Market Outlook
5.1.
Market Size &
Forecast
5.1.1.
By Value
5.2.
Market Share &
Forecast
5.2.1.
By Product
5.2.2. By Specialties
5.2.3.
By Delivery Mode
5.2.4. By Substances
5.2.5.
By Country
5.3.
Asia Pacific:
Country Analysis
5.3.1.
China E-Prescribing
Market Outlook
5.3.1.1.
Market Size & Forecast
5.3.1.1.1.
By Value
5.3.1.2.
Market Share & Forecast
5.3.1.2.1.
By Product
5.3.1.2.2.
By Specialties
5.3.1.2.3.
By Delivery Mode
5.3.1.2.4.
By Substances
5.3.2.
India E-Prescribing
Market Outlook
5.3.2.1.
Market Size & Forecast
5.3.2.1.1.
By Value
5.3.2.2.
Market Share & Forecast
5.3.2.2.1.
By Product
5.3.2.2.2.
By Specialties
5.3.2.2.3.
By Delivery Mode
5.3.2.2.4.
By Substances
5.3.3.
Australia E-Prescribing
Market Outlook
5.3.3.1.
Market Size & Forecast
5.3.3.1.1.
By Value
5.3.3.2.
Market Share & Forecast
5.3.3.2.1.
By Product
5.3.3.2.2.
By Specialties
5.3.3.2.3.
By Delivery Mode
5.3.3.2.4.
By Substances
5.3.4.
Japan E-Prescribing
Market Outlook
5.3.4.1.
Market Size & Forecast
5.3.4.1.1.
By Value
5.3.4.2.
Market Share & Forecast
5.3.4.2.1.
By Product
5.3.4.2.2.
By Specialties
5.3.4.2.3.
By Delivery Mode
5.3.4.2.4.
By Substances
5.3.5.
South Korea
E-Prescribing Market Outlook
5.3.5.1.
Market Size & Forecast
5.3.5.1.1.
By Value
5.3.5.2.
Market Share & Forecast
5.3.5.2.1.
By Product
5.3.5.2.2.
By Specialties
5.3.5.2.3.
By Delivery Mode
5.3.5.2.4.
By Substances
6. Europe E-Prescribing Market Outlook
6.1.
Market Size &
Forecast
6.1.1.
By Value
6.2.
Market Share &
Forecast
6.2.1. By Product
6.2.2. By Specialties
6.2.3. By Delivery Mode
6.2.4. By Substances
6.2.5. By Country
6.3.
Europe: Country
Analysis
6.3.1.
France E-Prescribing
Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Product
6.3.1.2.2.
By Specialties
6.3.1.2.3.
By Delivery Mode
6.3.1.2.4.
By Substances
6.3.2.
Germany
E-Prescribing Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Product
6.3.2.2.2.
By Specialties
6.3.2.2.3.
By Delivery Mode
6.3.2.2.4.
By Substances
6.3.3.
Spain E-Prescribing
Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Product
6.3.3.2.2.
By Specialties
6.3.3.2.3.
By Delivery Mode
6.3.3.2.4.
By Substances
6.3.4.
Italy E-Prescribing
Market Outlook
6.3.4.1.
Market Size & Forecast
6.3.4.1.1.
By Value
6.3.4.2.
Market Share & Forecast
6.3.4.2.1.
By Product
6.3.4.2.2.
By Specialties
6.3.4.2.3.
By Delivery Mode
6.3.4.2.4.
By Substances
6.3.5.
United Kingdom
E-Prescribing Market Outlook
6.3.5.1.
Market Size & Forecast
6.3.5.1.1.
By Value
6.3.5.2.
Market Share & Forecast
6.3.5.2.1.
By Product
6.3.5.2.2.
By Specialties
6.3.5.2.3.
By Delivery Mode
6.3.5.2.4.
By Substances
7. North America E-Prescribing Market Outlook
7.1.
Market Size &
Forecast
7.1.1.
By Value
7.2.
Market Share &
Forecast
7.2.1. By Product
7.2.2. By Specialties
7.2.3. By Delivery Mode
7.2.4. By Substances
7.2.5.
By Country
7.3.
North America:
Country Analysis
7.3.1.
United States
E-Prescribing Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Product
7.3.1.2.2.
By Specialties
7.3.1.2.3.
By Delivery Mode
7.3.1.2.4.
By Substances
7.3.2.
Mexico E-Prescribing
Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Product
7.3.2.2.2.
By Specialties
7.3.2.2.3.
By Delivery Mode
7.3.2.2.4.
By Substances
7.3.3.
Canada E-Prescribing
Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Product
7.3.3.2.2.
By Specialties
7.3.3.2.3.
By Delivery Mode
7.3.3.2.4.
By Substances
8. South America E-Prescribing Market Outlook
8.1.
Market Size &
Forecast
8.1.1.
By Value
8.2.
Market Share &
Forecast
8.2.1. By Product
8.2.2. By Specialties
8.2.3. By Delivery Mode
8.2.4. By Substances
8.2.5.
By Country
8.3.
South America:
Country Analysis
8.3.1.
Brazil E-Prescribing
Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Product
8.3.1.2.2.
By Specialties
8.3.1.2.3.
By Delivery Mode
8.3.1.2.4.
By Substances
8.3.2.
Argentina E-Prescribing
Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Product
8.3.2.2.2.
By Specialties
8.3.2.2.3.
By Delivery Mode
8.3.2.2.4.
By Substances
8.3.3.
Colombia
E-Prescribing Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Product
8.3.3.2.2.
By Specialties
8.3.3.2.3.
By Delivery Mode
8.3.3.2.4.
By Substances
9. Middle East and Africa E-Prescribing Market Outlook
9.1.
Market Size &
Forecast
9.1.1.
By Value
9.2.
Market Share &
Forecast
9.2.1. By Product
9.2.2. By Specialties
9.2.3. By Delivery Mode
9.2.4. By Substances
9.2.5.
By Country
9.3.
MEA: Country
Analysis
9.3.1.
South Africa
E-Prescribing Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Product
9.3.1.2.2.
By Specialties
9.3.1.2.3.
By Delivery Mode
9.3.1.2.4.
By Substances
9.3.2.
Saudi Arabia
E-Prescribing Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Product
9.3.2.2.2.
By Specialties
9.3.2.2.3.
By Delivery Mode
9.3.2.2.4.
By Substances
9.3.3.
UAE E-Prescribing
Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Product
9.3.3.2.2.
By Specialties
9.3.3.2.3.
By Delivery Mode
9.3.3.2.4.
By Substances
10.
Market Dynamics
10.1.
Drivers
10.2.
Challenges
11.
Market Trends &
Developments
11.1.
Recent Developments
11.2.
Product Launches
11.3.
Mergers &
Acquisitions
12.
Global E-Prescribing
Market: SWOT Analysis
13. Porter’s Five Forces Analysis
13.1.
Competition in the
Industry
13.2.
Potential of New
Entrants
13.3.
Power of Suppliers
13.4.
Power of Customers
13.5.
Threat of Substitute
Product
14.
Competitive
Landscape
14.1. Oracle Corp.
14.1.1. Business Overview
14.1.2.
Company Snapshot
14.1.3.
Product &
Services
14.1.4.
Financials (In case
of listed)
14.1.5.
Recent Developments
14.1.6.
SWOT Analysis
14.2. Veradigm LLC
14.3. Epic Systems Corporation
14.4. Athenahealth, Inc.
14.5. NextGen Healthcare, Inc.
14.6. McKesson Corporation
14.7. Surescripts, LLC
14.8. Change Healthcare LLC
14.9. Practice Fusion, Inc.
14.10.Networking Technology, Inc.
15.
Strategic Recommendations
16.
About Us & Disclaimer